Stockreport

Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Ac...

Aspire Biopharma Holdings, Inc.  (ASBP) 
PDF LOI to acquire DCS , a leading global automotive supplier with $200M+ in 2025 revenue, is not expected to require new equity raise to consummate the purchase ESTERO, [Read more]